Results 111 to 120 of about 79,269 (269)

Star and Stellar Cluster Formation: ALMA-SKA Synergies [PDF]

, 2015
G. A. Fuller, Jan Forbrich, J. M. Rathborne, Steven N. Longmore, S. Molinari   +4 more
openalex   +1 more source

Cell surface interactome analysis identifies TSPAN4 as a negative regulator of PD‐L1 in melanoma

Molecular Oncology, EarlyView.
Using cell surface proximity biotinylation, we identified tetraspanin TSPAN4 within the PD‐L1 interactome of melanoma cells. TSPAN4 negatively regulates PD‐L1 expression and lateral mobility by limiting its interaction with CMTM6 and promoting PD‐L1 degradation.
Guus A. Franken, Andrea Abel Gutierrez, Imke van Rossum, Cornelia G. Spruijt, Michiel Vermeulen, Guido van Mierlo, Blanca Scheijen, Annemiek B. van Spriel   +7 more
wiley   +1 more source

Formation of massive star clusters with and without iron abundance spreads in a dwarf galaxy merger [PDF]

Hidenori Matsui, Kenji Bekki, Madeleine McKenzie, Takayuki R. Saitoh   +3 more
openalex   +1 more source

Bar-Driven Star and Star Cluster Formations and Gas Fueling to Galactic Center [PDF]

, 2021
Hidenori Matsui, Toshiyasu Masakawa, Asao Habe, Takayuki R. Saitoh   +3 more
openalex   +1 more source

LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro

Molecular Oncology, EarlyView.
Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix, Daniel Samaga, Katharina Gehr, Benedek Dankó, Mohamed Schumann, Guido Drexler, Ahmed Alnatsha, Georg Beyer, Ujjwal Mahajan, Martin Selmansberger, Julia Mayerle, Claus Belka, Horst Zitzelsberger, Kirsten Lauber   +13 more
wiley   +1 more source

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

Molecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla, Jan Kosla, Magdalena Prechova, Lukas Frick, Patricia Bortel, Yasmin Borutzki, Andrea Bileck, Christopher Gerner, Samuel M. Meier‐Menches, Selma Osmanagic‐Myers, Martin Gregor   +10 more
wiley   +1 more source

JWST Observations of Starbursts: Massive Star Clusters in the Central Starburst of M82

The Astrophysical Journal Letters
We present a near-infrared (NIR) candidate star cluster catalog for the central kiloparsec of M82 based on new JWST NIRCam images. We identify star cluster candidates using the F250M filter, finding 1357 star cluster candidates with stellar masses >10 ^4
Rebecca C. Levy, Alberto D. Bolatto, Divakara Mayya, Bolivia Cuevas-Otahola, Elizabeth Tarantino, Martha L. Boyer, Leindert A. Boogaard, Torsten Böker, Serena A. Cronin, Daniel A. Dale, Keaton Donaghue, Kimberly L. Emig, Deanne B. Fisher, Simon C. O. Glover, Rodrigo Herrera-Camus, María J. Jiménez-Donaire, Ralf S. Klessen, Laura Lenkić, Adam K. Leroy, Ilse De Looze, David S. Meier, Elisabeth A. C. Mills, Juergen Ott, Mónica Relaño, Sylvain Veilleux, Vicente Villanueva, Fabian Walter, Paul P. van der Werf   +27 more
doaj   +1 more source

Single Millisecond Pulsars from Dynamical Interaction Processes in Dense Star Clusters [PDF]

Claire S. Ye, Kyle Kremer, S. M. Ransom, Frederic A. Rasio   +3 more
openalex   +1 more source

A Rich Cluster of Galaxies Near the Quasar B2 1335+28 atz= 1.1: Color Distribution and Star Formation Properties [PDF]

, 2001
Ichi Tanaka, Tōru Yamada, Alfonso Aragón‐Salamanca, Tadayuki Kodama, T. Miyaji, Kouji Ohta, N. Arimoto   +6 more
openalex   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source